In this module, we introduce you to the incretin hormone GLP-1 (glucagon-like peptide-1), its physiology, pathophysiology and mechanisms of action. We also appraise trial data on the use of GLP-1 receptor agonists to treat type 2 diabetes.
By the end of this module, you will be able to:
✓ Summarise the physiology of GLP-1 and the distribution of GLP-1 and its receptors around the body
✓ Explain the modes of action of GLP-1 in relation to key aspects of health and wellbeing for people with type 2 diabetes
✓ Outline how GLP-1 receptor agonists can be used in the management of type 2 diabetes based on trial evidence
This module includes self-marked assessments, such as knowledge checks and/or case studies, as well as a marked final assessment, which you can attempt up to five times. To complete the module, you must review all chapters, pass the final assessment (80% pass mark), and fill in our feedback form.